MRK vs ABBV
MRK and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MRKMerck & Co., Inc. | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $360.95B | $466.75B |
| P/E (TTM) | 117.0 | 74.6 |
| P/B | 8.61 | — |
| P/S | 5.6x | 7.6x |
| Dividend yield | 2.27% | 2.50% |
| Revenue | $66.57B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 1.3% | 8.6% |
| Net income | $3.17B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 6.6% | -1.2% |
| EPS, diluted | $1.25(TTM) | $3.54(TTM) |
| EBIT margin | 34.2% | 24.6% |
| ROE | 43.5% | — |
| ROIC | 21.6% | 18.6% |
| 1y total return | +83.4% | +21.8% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: MRK frente a ABBV
| Métrica | MRK | ABBV |
|---|---|---|
| Valor final | $37.1K | $66.6K |
| Retorno total | +270.8% | +566.1% |
| CAGR | +13.5% | +20.1% |
| Volatilidad | 23.3% | 25.9% |
| Sharpe | 0.49 | 0.68 |
| Sortino | 0.71 | 0.95 |
| Caída máxima | -43.4% | -45.1% |
Basado en 2600 días de negociación comunes, 2016-05-17 → 2026-09-18 · tasa libre de riesgo 4.12% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)